Literature DB >> 18053807

Laboratory differentiation of Cushing's syndrome.

Giuseppe Reimondo1, Anna Pia, Silvia Bovio, Barbara Allasino, Fulvia Daffara, Piero Paccotti, Giorgio Borretta, Alberto Angeli, Massimo Terzolo.   

Abstract

Cushing's syndrome (CS) is a complex of signs and symptoms due to chronic glucocorticoid excess from a variety of causes. Although CS is considered a rare disease, recent studies have suggested that it may be more frequent than previously expected in various clinical settings (i.e. subjects suffering from diabetes, osteoporosis or metabolic syndrome). If confirmed in large population-based studies, more widespread screening for CS may be warranted. Missed diagnosis of CS may have detrimental consequences because hypercortisolism, even if not clinically apparent, increases the probability of future cardiovascular events through induction/amplification of several risk factors (hypertension, central adiposity, thrombophilic state, etc.). Identifying CS has represented one of the most challenging problems for the clinical endocrinologist since no test is 100% sensitive and specific. This review article will be focus on diagnostic laboratory procedures that support a rationale approach in the screening evaluation and in the differential diagnosis of the endogenous CS. Notwithstanding the difficulties derived from laboratory reliability and the adoption of a hormonal cut-off close to the sensitivity of many commercially available assays, an increasing amount of data have provided novel information aimed to meet the demand of inexpensive, convenient and reliable laboratory procedures.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18053807     DOI: 10.1016/j.cca.2007.10.036

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

1.  Children with Cushing's syndrome: Primary Pigmented Nodular Adrenocortical Disease should always be suspected.

Authors:  Renata Marques Gonçalves da Silva; Emília Pinto; Suzan M Goldman; Cássio Andreoni; Teresa C Vieira; Julio Abucham
Journal:  Pituitary       Date:  2011-03       Impact factor: 4.107

Review 2.  Cushing's syndrome: why is diagnosis so difficult?

Authors:  David C Aron
Journal:  Rev Endocr Metab Disord       Date:  2010-06       Impact factor: 6.514

3.  PseudoCushing: why a clinical challenge?

Authors:  F Pecori Giraldi
Journal:  J Endocrinol Invest       Date:  2015-04-28       Impact factor: 4.256

4.  Reliability of the diagnostic tests for Cushing's syndrome performed in a tertiary referral center.

Authors:  Mutlu Günes; Ozlem Celik; Pinar Kadioglu
Journal:  Pituitary       Date:  2013-06       Impact factor: 4.107

5.  Hair analysis provides a historical record of cortisol levels in Cushing's syndrome.

Authors:  S Thomson; G Koren; L-A Fraser; M Rieder; T C Friedman; S H M Van Uum
Journal:  Exp Clin Endocrinol Diabetes       Date:  2009-07-16       Impact factor: 2.949

6.  Whom Should We Screen for Cushing Syndrome? The Endocrine Society Practice Guideline Recommendations 2008 Revisited.

Authors:  Leah T Braun; Frederick Vogel; Stephanie Zopp; Thomas Marchant Seiter; German Rubinstein; Christina M Berr; Heike Künzel; Felix Beuschlein; Martin Reincke
Journal:  J Clin Endocrinol Metab       Date:  2022-08-18       Impact factor: 6.134

Review 7.  Toward a Diagnostic Score in Cushing's Syndrome.

Authors:  Leah T Braun; Anna Riester; Andrea Oßwald-Kopp; Julia Fazel; German Rubinstein; Martin Bidlingmaier; Felix Beuschlein; Martin Reincke
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-08       Impact factor: 5.555

8.  Indication to dynamic and invasive testing in Cushing's disease according to different neuroradiological findings.

Authors:  E Ferrante; M Barbot; A L Serban; F Ceccato; G Carosi; L Lizzul; E Sala; A Daniele; R Indirli; M Cuman; M Locatelli; R Manara; M Arosio; M Boscaro; G Mantovani; C Scaroni
Journal:  J Endocrinol Invest       Date:  2021-10-26       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.